Our large-scale and prospective pharmacogenomics study of Japanese patients receiving protocol treatment of adjuvant mFOLFOX6 could not verify a role for any of the 12 SNP markers reported as being significantly associated with oxaliplatin-induced peripheral sensory neuropathy.
from Cancer via ola Kala on Inoreader http://ift.tt/1oytFAD
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου